Jaap Jan Boelens MD PhD (He/Him)

Pediatric Hematology & Oncology•New York, NY

Chief, Transplantation and Cellular Therapies

Request Appointment

1275 York AvenueNew York, NY 10065
Book by Phone+1(712) 628-6486

Education & Training

Utrecht University Faculty of MedicineClass of 1996

Certifications & Licensure

FL State Medical License 2022 - Present
NY State Medical License 2019 - 2027

Clinical Trials

US Study of ECT-001-CB in Pediatric and Young Adult Patients With High-Risk Myeloid Malignancies Start of enrollment: 2021 Dec 01
RECRUITING
PHASE1, PHASE2
Roles: Contact
Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders Start of enrollment: 2020 Nov 20
RECRUITING
PHASE2
Roles: Contact
Conditioning SCID Infants Diagnosed Early Start of enrollment: 2018 Oct 22
RECRUITING
PHASE2
Roles: Principal Investigator, Contact
Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCT Start of enrollment: 2022 Mar 31
Recruiting
Phase 1, Phase 2
A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT) Start of enrollment: 2023 Feb 09
Recruiting
Phase 2
Roles: Contact
Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AML Start of enrollment: 2022 Oct 06
TERMINATED
PHASE1
Roles: Contact
A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition Start of enrollment: 2023 Mar 15
RECRUITING
PHASE2
A Study of Emapalumab for Pediatric Aplastic Anemia Start of enrollment: 2024 May 21
RECRUITING
PHASE2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Perspectives on the current diagnostic and treatment paradigms in secondary hemophagocytic lymphohistiocytosis (HLH).
Leonard Naymagon, Philip Roehrs, Michelle Hermiston, James Connelly, Jeffrey Bednarski
Orphanet Journal of Rare Diseases. 2025-04-26
Successful hematopoietic cell transplantation utilizing myeloablative reduced-toxicity conditioning in Chediak-Higashi syndrome.
Alan Bidgoli, Binni Kunvarjee, Andromachi Scaradavou, Richard J O'Reilly, Jaap Jan Boelens
The Journal of Allergy and Clinical Immunology. 2025-02-01
1 citations
The role of the conditioning regimen for autologous and ex vivo genetically modified hematopoietic stem cell-based therapies: recommendations from the ISCT stem cell e...
Joseph H Oved, Athena Russell, Amy DeZern, Susan E Prockop, Carmem Bonfim
Cytotherapy. 2025-01-01

Abstracts/Posters

Allogeneic CD34-Selected HSCT Following CAR T-Cells Is Associated with Low TRM and Favorable OS in Pediatric/Young Adult Patients with Relapsed/Refractory B-ALL
Jaap Jan Boelens, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

Gene Therapy May Be a Game Changer for Transfusion-Dependent ThalassemiaFebruary 7th, 2025
No Matched Sibling Donor? Sickle Cell Experts Debate Next-Best OptionSeptember 16th, 2024

Committees

VP North America, ISCT (international society cell and gene therapy) 2024 - Present

Professional Memberships

American Society of Hematology - ASH
Member
ISCT
Member

Other Languages

Dutch